Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Regulatory / Regencell Bioscience Securities Class Action
Regulatory securities lawsuit

Regencell Bioscience Securities Class Action

Analysis based on 6 articles · First reported May 03, 2026 · Last updated May 17, 2026

Sentiment
-50
Attention
4
Articles
6
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

The market is impacted by the significant drop in Regencell Bioscience Holdings' share price due to allegations of market manipulation and a United States — United States Department of Justice investigation. This event highlights the risks associated with investing in companies facing regulatory scrutiny and potential legal liabilities.

Biotechnology Legal Services
Event Summary

Regencell Bioscience Holdings is facing a federal securities class action lawsuit led by Faruqi & Faruqi, alleging that the company and its executives made false and misleading statements and were vulnerable to market manipulation. This led to significant volatility in its ordinary shares and exposed investors to financial risk. The situation escalated when Regencell Bioscience Holdings disclosed on October 31, 2025, that it received a subpoena from the United States — United States Department of Justice, indicating an investigation into the trading of its shares. Following this news, Regencell Bioscience Holdings' share price fell by 18.56%. Investors who suffered losses between October 28, 2024, and October 31, 2025, are encouraged to seek lead plaintiff status in the class action by the June 23, 2026 deadline.

Key Actions
100 Regencell Bioscience Holdings disclosed investigation United States — United States Department of Justice
95 Regencell Bioscience Holdings fell in share price
90 Faruqi & Faruqi investigated claims Regencell Bioscience Holdings
Entities Involved
stock
Regencell Bioscience Holdings
Regencell Bioscience Holdings is facing a federal securities class action lawsuit due to alleged market manipulation and misleading statements, which led to a significant drop in its share price and a U.S. Department of Justice investigation.
Importance 100 Sentiment -70
priv
Faruqi & Faruqi
Faruqi & Faruqi, a national securities law firm, is investigating potential claims against Regencell Bioscience Holdings and is encouraging investors to join the class action lawsuit.
Importance 80 Sentiment 20
govactor
United States — United States Department of Justice
The United States — United States Department of Justice is conducting an investigation into the trading of Regencell Bioscience Holdings' ordinary shares, indicating potential regulatory scrutiny and enforcement action.
Importance 70 Sentiment 0
index
Nasdaq-100
Regencell Bioscience Holdings' shares are traded on Nasdaq-100, which is the exchange where the volatility and subsequent price drop occurred.
Importance 10 Sentiment 0
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.